BioClinica ($BIOC), a provider of clinical trials software and imaging core lab services, saw its profits fall in the third quarter. The company's GAAP net income fell from $808,000 in the third quarter of last year to $358,000 in the recent third quarter. Yet its quarterly revenue was up from $18.3 million to $21.5 million, RTTNews reported. Article